rs142896669
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP5BS1_SupportingBP2
This summary comes from the ClinGen Evidence Repository: The NM_001114753.3: c.1633G>A variant in ENG is a missense variant predicted to cause substitution of glycine by serine at amino acid 545 (p.Gly545Ser). The filtering allele frequency (the lower threshold of the 95% CI of 54/35,428 alleles) of the c.1633G>A variant in ENG is 0.1% for Admixed American chromosomes by gnomAD v2.1.1, which is higher than the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel threshold (>0.08%) for BS1_Supporting, and therefore meets this criterion (BS1_Supporting). This variant has been observed in trans with the variant c.391_392del, p.(Pro131Glyfs*17) (PMID:18498373) which is classified as likely pathogenic (PMID:18498373) in an individual with hereditary hemorrhagic telangiectasia. The phase of the variants was confirmed by family testing (BP2). This variant has been observed in at least two patients with an alternate molecular basis for disease (likely pathogenic/pathogenic variants identified in ACVRL1) (BP5; internal lab contributors). The computational predictor REVEL gives a score of 0.399, which is neither above nor below the thresholds predicting a damaging or benign impact on ENG function. In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: BS1_Supporting, BP2, BP5 (specifications version 1.1.0; 09/11/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5252712/MONDO:0008535/136
Frequency
Consequence
NM_001114753.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile polyposis syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001114753.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | MANE Select | c.1633G>A | p.Gly545Ser | missense | Exon 12 of 15 | NP_001108225.1 | P17813-1 | ||
| ENG | c.1633G>A | p.Gly545Ser | missense | Exon 12 of 14 | NP_000109.1 | Q5T9B9 | |||
| ENG | c.1087G>A | p.Gly363Ser | missense | Exon 12 of 15 | NP_001265067.1 | F5GX88 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | TSL:1 MANE Select | c.1633G>A | p.Gly545Ser | missense | Exon 12 of 15 | ENSP00000362299.4 | P17813-1 | ||
| ENG | TSL:1 | c.1633G>A | p.Gly545Ser | missense | Exon 12 of 14 | ENSP00000341917.3 | P17813-2 | ||
| ENG | c.1633G>A | p.Gly545Ser | missense | Exon 12 of 15 | ENSP00000519338.1 | A0AAQ5BHC4 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152194Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000521 AC: 131AN: 251296 AF XY: 0.000456 show subpopulations
GnomAD4 exome AF: 0.000666 AC: 973AN: 1461876Hom.: 2 Cov.: 31 AF XY: 0.000660 AC XY: 480AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000361 AC: 55AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at